261 related articles for article (PubMed ID: 28081297)
1. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots.
Xiong Y; Jeronis S; Hoffman B; Liebermann DA; Geifman-Holtzman O
Prenat Diagn; 2017 Apr; 37(4):311-317. PubMed ID: 28081297
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
3. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
[TBL] [Abstract][Full Text] [Related]
4. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
6. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma.
Sedrak M; Hashad D; Adel H; Azzam A; Elbeltagy N
Genet Test Mol Biomarkers; 2011 Sep; 15(9):627-31. PubMed ID: 21488716
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
[TBL] [Abstract][Full Text] [Related]
8. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
[TBL] [Abstract][Full Text] [Related]
9. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy.
Costa JM; Giovangrandi Y; Ernault P; Lohmann L; Nataf V; El Halali N; Gautier E
Br J Haematol; 2002 Oct; 119(1):255-60. PubMed ID: 12358932
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive fetal RHD genotyping for RhD negative women stratified into RHD gene deletion or variant groups: comparative accuracy using two blood collection tube types.
Hyland CA; Millard GM; O'Brien H; Schoeman EM; Lopez GH; McGowan EC; Tremellen A; Puddephatt R; Gaerty K; Flower RL; Hyett JA; Gardener GJ
Pathology; 2017 Dec; 49(7):757-764. PubMed ID: 29096879
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(15):1-160. PubMed ID: 33240456
[TBL] [Abstract][Full Text] [Related]
12. [Non invasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women].
Carbonne B; Cortey A; Rouillac-Le Sciellour C; Brossard Y
Gynecol Obstet Fertil; 2008 Feb; 36(2):200-203. PubMed ID: 18243756
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.
Clausen FB; Barrett AN;
Vox Sang; 2019 May; 114(4):386-393. PubMed ID: 30834546
[TBL] [Abstract][Full Text] [Related]
15. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
[TBL] [Abstract][Full Text] [Related]
16. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
Zhu YJ; Zheng YR; Li L; Zhou H; Liao X; Guo JX; Yi P
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1839-44. PubMed ID: 24422551
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
[TBL] [Abstract][Full Text] [Related]
19. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
Geifman-Holtzman O; Grotegut CA; Gaughan JP
Am J Obstet Gynecol; 2006 Oct; 195(4):1163-73. PubMed ID: 17000250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
